Osteonecrosis of the jaws by long term therapy with bisphosphonates;Osteonekrose der Kiefer unter Bisphosphonat-Langzeittherapie

Mund - Kiefer - und Gesichtschirurgie

Volumn 10, Issue 5, 2006, Pages 287-300

  Piesold, Jörn Uwe ^a   Al Nawas, Bilal ^b   Grötz, Knut A ^c  

^a HELIOS KLINIKUM ERFURT   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c DR HORST SCHMIDT KLINIKEN   (Germany)

Author keywords

Bisphosphonates; Bone metastases; Clinical symptoms; Diagnostics; Interdisciplinary care; Malign diseases; Osteonecrosis of the jaws; Prophylaxis; Therapy

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ANIMAL; ARTICLE; BONE NECROSIS; BONE TUMOR; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; HUMAN; JAW; JAW DISEASE; LONG TERM CARE; METASTASIS; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; PANORAMIC RADIOGRAPHY; PATHOLOGY; SUPERINFECTION;

ALVEOLAR PROCESS; ANIMALS; BONE NEOPLASMS; DIPHOSPHONATES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; JAW DISEASES; LONG-TERM CARE; OSTEOBLASTS; OSTEOCLASTS; OSTEONECROSIS; OSTEOPOROSIS; RADIOGRAPHY, PANORAMIC; SUPERINFECTION;

EID: 33748913160     PISSN: 14329417     EISSN: 14343940     Source Type: Journal    
DOI: 10.1007/s10006-006-0017-5     Document Type: Article

References (62)

1. Abu-Id MH, Acil Y Gottschalk J, Kreusch T (2006) Bisphosphonatassoziierte Osteonekrose des Kiefers. Mund Kiefer Gesichtschir 10(2):73-81
2. Al-Nawas B (2002) Stellungnahme der DGZMK - Einsatz von Antibiotika in der zahnärztlichen Praxis. ZM 92:32-36
3. Al-Nawas B. Duschner H. Grötz K.A. 2004 Early cellular Alteration in Bone after Radiation Therapy and its Relation to Osteoradionecrosis. J Oral Maxillofac Surg 62 1045-1048
4. Arzneimittelkommission der deutschen Ärzteschaft (2004) "UAW-News" - International Osteonekrosen des Kiefers unter Bisphosphonaten. Deutsches Ärzteblatt 31/32:B1843
5. Arzneimittelkommission der Deutschen Äzteschaft "Aus der UAW-Datenbank" Psychiatrische UAW unter Bisphosphonat-Therapie: Verwirrtheit nach Einnahme von Alendronsäure (Fosamax?)
6. Bagan JV, Murillo J, Jimenez Y et al. (2005) Avascular jaw osteonecrosis in association with cancer chemotherapy: Series of 10 cases. J Oral Pathol Med 34:120-123
7. Bamias A, Kastritis E, Bamia C et al. (2005) Osteonecrosis of the jaw in cancer after treatment with Bisphosphonates: Incidence and risk factors. J Clin Oncol 23:8580-8587
8. Bartl R (2001) Bisphosphonate Manual Supportive Maßnahmen und symptomorientierte Therapie. Tumorzentrum, München 184-190
9. Bartl R, Bartl C (2004) Osteoporose-Manual Diagnostik, Prevention und Therapie. Springer Verlag Berlin, Heidelberg
10. Berenson J (2002) Advances in the biology and treatment of myeloma bone desease. Semin Oncol 29:11-16
11. Boissier S, Ferreras M, Peyruchaud O, Magnetto S, Ebetino FH et al. (2000) Bisphosphonates inhibit breast an prostate carcinoma cell invasion, an early event in the formation of bone metastases. Cancer Res 60:2949-2954
12. Carter GD, Goss AN (2003) Bisphosphonates and avascular necrosis of the jaw. Aust Dent J 48:268
13. Damato K, Gralow J, Hoff A, Huryn J, Marx R, Ruggiero S, Schubert M, Toth B, Valero V (2004) Empfehlungen eines Expertengremiums zur Prävention, Diagnose und Behandlung einer Kiefer-Osteonekrose. nicht publiziert, als Manuskript vorliegend
14. Degidi M, Piatelli A (2003) Immediately loaded bar-connected implants with an annodized surface inserted in the anterior mandible in a patient treated with diphosphonates for osteoporosis: A case report with a 12-month follow-up. Clin Implant Dent Relat Res 5(4):269-272
15. Diel IJ, Bergner R, Grötz KA (2005) Bisphosphonate und ihre häufigsten Nebenwirkungen. J Onkologie 5:6-12
16. Diel IJ, Solomayer EF, Bastert G (2000) Bisphosphonates and the prevention of metastasis: First evidences from preclinical and clinical studies. Cancer 88:3080-3088
17. Diel IJ, Solomayer EF, Bastert G (1998) Reduction in new metastases in breast cancer with adjuvant clodronate treatment. N Engl J Med 339:357-363
18. Ficarra G, Beninati F, Rubino I, Vannucchi A, Longo G, Tonelli P, Pini Prato G (2005) Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol 32:1123-1128
19. Greenberg MS (2004) Intravenous bisphosphonates and osteonecrosis. Oral Surg Oral Pathol Oral Radiol Endod 98:259-260
20. Grötz KA (2001) Prophylaxe und Therapie der Folgen therapeutischer Tumor-Bestrahlung im Mund-Kiefer-Gesichtsbereich. Quintessenz, Berlin
21. Grötz KA (2002) Zahnärztliche Betreuung von Patienten mit tumortherapeutischer Kopf-Hals-Bestrahlung (Wissenschaftliche Stellungnahme der DGZMK und DEGRO). Dtsch Zahnärztl Z 57:509-11
22. Grötz KA (2003) Zahnärztliche Betreuung von Patienten mit tumortherapeutischer Kopf-Hals-Bestrahlung (Wissenschaftliche Stellungnahme der DGZMK und DEGRO). Strahlenther Onkol 179:275-8
23. Grötz KA, Al-Nawas B (2006) "Persisting alveolar sockets" - A radiologic symptom of Bisphosphonat associated osteonecrosis of the jaw (BP-ONJ)? J Oral Maxillofac Surg (eingereicht)
24. Grötz KA, Al-Nawas B, Kutzner J, et al. (2001) Ätiologie der infizierten Osteoradionekrose des Kiefer-Gesichts-Bereiches: Einfluss der periradiotherapeutischen Betreuung. Dtsch Zahnärztl Z 56:43-46
25. Grötz KA, Diel IJ (2005) Ostteonekrose des Kiefers unter Bisphosphonat-Langzeittherapie. Im Focus Oncologie 3:52-55
26. Grötz KA, Wahlmann UW, Krummenauer F, Wegener J, Al-Nawas B, Kuffner H-D, Wagner W (1999) Prognose und Prognosefaktoren enossaler Implantate im bestrahlten Kiefer. Mund Kiefer Gesichtschir 3:117-124
27. Grötz KA, Walter C, Küttner C, Al-Nawas B (2006) Zur Relevanz einer Bisphosphonat-Langzeittherapie bei der Strahelntherapie enossaler Kiefermetastasen. Strahlenther Onkol (eingereicht)
28. Hellstein JW, Marek CL (2004) Bis-phossy jaw, phossy jaw, and the 21th century: Bisphosphonate-associated complications of the jaws. J Oral Maxillofac Surg 62:1563-1565
29. Hoefert S, Eufinger H (2004) mögliche unerwünschte Wirkungen von Bisphosphonaten im Kieferbereich. Zm 94(19):2466-2469
30. Hoefert S, Eufinger H (2005) Kieferknochennekrosen als mögliche unerwünschte Wirkung von Bisphosphonaten. Mund Kiefer Gesichtschir 9(4):233-238
31. Luckmann SP, Hughes D, Coxon FP et al. (1998) Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP binding proteins, including Ras. J Bone Miner Res 13:581-589
32. Lugassy G, Shaham R, Nemets A, Ben-Dor D, Nahlieli O (2004) Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity. Am J Med 117:440-441
33. Maerevoet M, Martin C, Duck L (2005) Osteonecrosis of the jaw and bisphosphonates (letter). N Engl J Med 353:100-101
34. Marx RE (1983a) Osteoradionecrosis: A new concept of its pathophysiologie. J Oral Maxillofac Surg 41:283-288
35. Marx RE (1983b) A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg 41:351-357
36. Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avaskular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg 61:1215-1217
37. Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bispohosphonate induced exposed bone (osteonecrosis osteopetrosis) of the jaws: Risc factors, recognicion, prevention and treatment. J Oral Maxillofac Surg 63:1567-1575
38. Melo MD, Obeid G (2005) Osteonecrosis of the maxilla in a patient with history of bisphosphonate therapy. J Can Dent Assoc 71:111-113
39. Migliorati CA (2003) Bisphosponates and oral cavità avascular bone necrosis. J Clin Oncol 21:4253-4254
40. Migliorati CA (2005a) Managing the care of patients with bisphosphonate-associated osteonecrosis. JADA 136:1658-1668
41. Migliorati CA, Schubert MM, Peterson DE, Seneda LM (2005b) Bisphosphate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 104:83-93
42. Pistner H, Piesold J (2006) Nur die Spitze des Eisbergs? - Kieferosteonekrosen nach Bisphosphonat-Therapie von Tumor- und Osteonekrose-Pateinten - Ärztebl Thür 17 (eingereicht)
43. Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Belliodo T (1999) Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 204:1363-1374
44. Pluijm G, Vloedgraven H, Beek van E, Weels-Paals van der L, Löwick C, Papapolous S (1996) Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrix. J Clin Invest 98:689-705
45. Pogrel MA (2003) Bisphosphonates and bone necrosis. J Oral Maxillofac Surg 61:1104-1107
46. Purcell PM, Boyd IW (2005) Bisphosphonates and osteonecrosis of the jaw. Med J Aust 182:417-418
47. Robinson NA, Yeo JF (2004) Bisphosphonates - a word of caution. Ann Acad Med Singapore 33(4 Suppl):48-49
48. Rothstein JP (2004) Cancer chemotherapy and oral care. Dent Today 23:86-91
49. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases. J Oral Maxillofac Surg 62:527-534
50. SaartoT, Blomquist C, Virkkunen P, Elomaa I (1999) No reduction of bone metastases with adjuvang clodronate treatment in node-positive breast cancer patients. Proc Am Soc Clin Oncol 18:aBstract489
51. Sarathy AP, Bourgeois Jr SL, Goodell GG (2005) Bisphosphonate associated osteonecrosis of the jaws and endodontic treatment: Two case reports. J Endod 31(10):759-763
52. Savage AD (1996) Pamidronate reduce IL-6 production by bone marrow stroma from multiple myeloma patients. Blood 85:105
53. Schirmer I, Peters H, Reichart PA, Dürkop H (2005) Bisphosphonate und Osteonekrosen im Kieferbereich. Mund Kiefer Gesichtschir 9(4):239-245
54. Schmid P (2005) Pharmakologie der Bisphosphonate. In: Schmid P, Possinger K (Hrsg) Supportive Therapie von Knochenmetastasen. Uni-Med Verlag Bremen, London, Boston, 2.Auflage, S 78-90
55. Schwarz HC (1995) Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis - a case report. Int J Oral Maxillofac Implants 10:74-76
56. Schwarz HC (2004) Osteonecrosis and bisphosphonates: Correlation versus causation. J Oral Maxillofac Surg 62:763-764
57. Tarassoff P, Csermak K (2003) Avascular necrosis of the jaws: Risk factors in metastatic cancer patients. J Oral Maxillofac Surg 61:1238-1239
58. Vannucchi AM, Ficarra G, Antonioli E, Bosi A (2005) Osteonecrosis of the jaw associated with zeledronate therapy in a patient with multiple myeloma. Br J Haematol 128:738
59. Viale PH, Lin A (2005) Exposed bone in oral cavities. J Clin Oncol Nursing 9(3):355-357
60. Vogel F, Scholz H, Al-Nawas B, Elies W, Kresken M, Lode H, Müller O, Naber KG, Petersen E, Shah PM, Sörgel F, Stille W, Tauchnitz C, Trautmann M, Ullmann U, Wacha H, Weidemann R (2002) Rationaler Einsatz oraler Antibiotika bei Erwachsenen: Empfehlungen einer Expertenkommission der Paul Ehrlich-Gesellschaft für Chemotherapie e.V. Chemother J 11:47-58
61. Wang J, Goodger NM, Pogrel MA (2003) Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 61:1104-1107
62. Yoneda T, Sasaki A, Dunstan C, Williams PJ, Bauss F, De Clerck YA, Mundy GR (1997) Inhibition of osteolytic bone metastasis of breast cancer cells by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase 2. J Clin Invest 99:2509-2517